Joshua Dennerlein
Stock Analyst at B of A Securities
(2.17)
# 2,760
Out of 4,876 analysts
95
Total ratings
43.08%
Success rate
-4.38%
Average return
Main Sectors:
Stocks Rated by Joshua Dennerlein
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| FVR FrontView REIT | Downgrades: Underperform | $15 → $11 | $12.38 | -11.15% | 2 | Jun 17, 2025 | |
| SUI Sun Communities | Maintains: Underperform | $124 → $132 | $126.64 | +4.23% | 3 | May 12, 2025 | |
| TRI Thomson Reuters | Reinstates: Neutral | $180 | $197.93 | -9.06% | 1 | Apr 10, 2025 | |
| CTAS Cintas | Reinstates: Buy | $250 | $220.75 | +13.25% | 1 | Apr 10, 2025 | |
| MSCI MSCI Inc. | Initiates: Neutral | $585 | $576.41 | +1.49% | 1 | Apr 10, 2025 | |
| VRSK Verisk Analytics | Reinstates: Underperform | $280 | $308.66 | -9.29% | 1 | Apr 10, 2025 | |
| WELL Welltower | Maintains: Buy | $221 → $242 | $152.13 | +59.07% | 7 | Feb 18, 2025 | |
| GTY Getty Realty | Upgrades: Buy | $31 → $34 | $27.63 | +23.05% | 3 | Oct 21, 2024 | |
| AHR American Healthcare REIT | Maintains: Buy | $27 → $31 | $36.07 | -14.06% | 2 | Sep 24, 2024 | |
| NHI National Health Investors | Initiates: Buy | $92 | $70.84 | +29.87% | 1 | Sep 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $307 → $321 | $285.41 | +12.47% | 3 | Sep 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $100 | $44.09 | +126.81% | 1 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $111 → $147 | $113.76 | +29.22% | 4 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $144 → $189 | $147.85 | +27.83% | 3 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $45 → $40 | $57.55 | -30.50% | 4 | May 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $18 → $25 | $17.36 | +44.01% | 2 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $33 → $31 | $36.58 | -15.25% | 11 | Jan 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $48 → $53 | $62.88 | -15.71% | 9 | Jan 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $18 → $6 | $6.96 | -13.79% | 1 | Nov 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $42 → $33 | $40.71 | -18.94% | 1 | Oct 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $20 → $15 | $16.79 | -10.66% | 2 | Oct 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $52 | $57.03 | -8.82% | 1 | Oct 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $18.26 | - | 4 | Oct 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $67 → $54 | $62.87 | -14.11% | 4 | Sep 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $9 → $8 | $4.46 | +79.37% | 9 | Aug 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | $27 | $13.34 | +102.40% | 1 | Jun 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $28 → $34 | $16.87 | +98.58% | 5 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $31.93 | - | 4 | Aug 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $76 → $78 | $72.35 | +7.81% | 2 | Jun 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $52 → $47 | $42.88 | +9.61% | 2 | Jan 20, 2022 |
FrontView REIT
Jun 17, 2025
Downgrades: Underperform
Price Target: $15 → $11
Current: $12.38
Upside: -11.15%
Sun Communities
May 12, 2025
Maintains: Underperform
Price Target: $124 → $132
Current: $126.64
Upside: +4.23%
Thomson Reuters
Apr 10, 2025
Reinstates: Neutral
Price Target: $180
Current: $197.93
Upside: -9.06%
Cintas
Apr 10, 2025
Reinstates: Buy
Price Target: $250
Current: $220.75
Upside: +13.25%
MSCI Inc.
Apr 10, 2025
Initiates: Neutral
Price Target: $585
Current: $576.41
Upside: +1.49%
Verisk Analytics
Apr 10, 2025
Reinstates: Underperform
Price Target: $280
Current: $308.66
Upside: -9.29%
Welltower
Feb 18, 2025
Maintains: Buy
Price Target: $221 → $242
Current: $152.13
Upside: +59.07%
Getty Realty
Oct 21, 2024
Upgrades: Buy
Price Target: $31 → $34
Current: $27.63
Upside: +23.05%
American Healthcare REIT
Sep 24, 2024
Maintains: Buy
Price Target: $27 → $31
Current: $36.07
Upside: -14.06%
National Health Investors
Sep 24, 2024
Initiates: Buy
Price Target: $92
Current: $70.84
Upside: +29.87%
Sep 24, 2024
Downgrades: Neutral
Price Target: $307 → $321
Current: $285.41
Upside: +12.47%
Aug 19, 2024
Initiates: Buy
Price Target: $100
Current: $44.09
Upside: +126.81%
Aug 12, 2024
Upgrades: Buy
Price Target: $111 → $147
Current: $113.76
Upside: +29.22%
Aug 12, 2024
Upgrades: Buy
Price Target: $144 → $189
Current: $147.85
Upside: +27.83%
May 20, 2024
Downgrades: Underperform
Price Target: $45 → $40
Current: $57.55
Upside: -30.50%
Apr 1, 2024
Upgrades: Buy
Price Target: $18 → $25
Current: $17.36
Upside: +44.01%
Jan 16, 2024
Downgrades: Neutral
Price Target: $33 → $31
Current: $36.58
Upside: -15.25%
Jan 16, 2024
Upgrades: Buy
Price Target: $48 → $53
Current: $62.88
Upside: -15.71%
Nov 7, 2023
Downgrades: Underperform
Price Target: $18 → $6
Current: $6.96
Upside: -13.79%
Oct 31, 2023
Downgrades: Neutral
Price Target: $42 → $33
Current: $40.71
Upside: -18.94%
Oct 10, 2023
Downgrades: Underperform
Price Target: $20 → $15
Current: $16.79
Upside: -10.66%
Oct 10, 2023
Downgrades: Neutral
Price Target: $52
Current: $57.03
Upside: -8.82%
Oct 10, 2023
Upgrades: Buy
Price Target: n/a
Current: $18.26
Upside: -
Sep 26, 2023
Maintains: Underperform
Price Target: $67 → $54
Current: $62.87
Upside: -14.11%
Aug 11, 2023
Downgrades: Underperform
Price Target: $9 → $8
Current: $4.46
Upside: +79.37%
Jun 13, 2023
Initiates: Underperform
Price Target: $27
Current: $13.34
Upside: +102.40%
Nov 14, 2022
Upgrades: Buy
Price Target: $28 → $34
Current: $16.87
Upside: +98.58%
Aug 24, 2022
Upgrades: Buy
Price Target: n/a
Current: $31.93
Upside: -
Jun 2, 2022
Upgrades: Buy
Price Target: $76 → $78
Current: $72.35
Upside: +7.81%
Jan 20, 2022
Downgrades: Underperform
Price Target: $52 → $47
Current: $42.88
Upside: +9.61%